All In Biotech

Drug Trial Radar · NCT07556393

Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis

A Randomized, Double-blind, Placebo-controlled, Environmental Exposure Unit Trial of Intranasal INI-2004 in Subjects With Ragweed-induced Allergic Rhinitis

Last checked: Nov 19, 2026Latest source record: Apr 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

78

Actual

Start

Jan 19, 2026

Primary completion

Apr 23, 2026

Study completion Apr 23, 2026

Sponsor

Lead sponsor
Inimmune CorporationIndustry
Sponsor type
Industry
Collaborators
Rho, Inc.
First posted
Apr 29, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this trial is to see how well an experimental nasal spray, called INI-2004, works for those with allergy symptoms to ragweed. This nasal spray will compare how well 500mcg of INI-2004, given once per week for 4 weeks, works at reducing ragweed allergy symptoms in an Environmental Exposure Unit (EEU), compared to placebo.

Conditions

  • Allergic Rhinitis Due to Allergens
  • Rhinitis Allergic
  • Allergic Rhinitis

Interventions

  • INI-2004Drug

    Toll-like receptor \[TLR\]4 agonist liposomal formulation

  • PlaceboOther

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of incidence, severity and relationship of treatment-emergent adverse events (TEAEs), leading to discontinuation of study treatmentTime frame: Baseline (SV2) vs Day 24
  2. Calculate the change from baseline (SV2) vs D24 in Total Nasal Symptom Score (TNSS) during the chamber exposure (AUC0-180) for all subjectsTime frame: Baseline (SV2) vs Day 24

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Kingston Health Sciences Centre- KGH site

    Kingston, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.